Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The risk of COVID hospital admission and COVID mortality during the first COVID 19 wave with a special emphasis on Ethnic Minorities: an observational study of a single, deprived, multi ethnic UK health economy

View ORCID ProfileBaldev M Singh, View ORCID ProfileJames Bateman, Ananth Viswanath, Vijay Klaire, Sultan Mahmud, View ORCID ProfileAlan M Nevill, View ORCID ProfileSimon J Dunmore
doi: https://doi.org/10.1101/2020.11.20.20224691
Baldev M Singh
1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, WV10 0QP, UK
2School of Medicine and Clinical Practice, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, WV1 1LY, UK
Roles: Consultant, Medical Director
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Baldev M Singh
  • For correspondence: baldev.singh@nhs.net
James Bateman
1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, WV10 0QP, UK
Roles: Consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James Bateman
Ananth Viswanath
1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, WV10 0QP, UK
Roles: Consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vijay Klaire
1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, WV10 0QP, UK
Roles: Integrated Care Business Intelligence Lead
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sultan Mahmud
1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton, WV10 0QP, UK
3Faculty of Health, Education & Life Sciences, Birmingham City University, Birmingham, B15 3TN
Roles: Director of Innovation, Integration and Research
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan M Nevill
4Faculty of Education Health & Wellbeing, University of Wolverhampton, Walsall Campus, Walsall, WS1 3BD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alan M Nevill
Simon J Dunmore
2School of Medicine and Clinical Practice, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, WV1 1LY, UK
Roles: Reader
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon J Dunmore
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To address the generalisability of COVID-19’s outcomes to the well-defined but diverse communities of a single City area.

Design An observational study of COVID-19 outcomes using quality-assured and integrated data from a single UK hospital contextualised to its feeder population and its associated factors (comorbidities, ethnicity, age, deprivation).

Setting/Participants Single city hospital with a feeder population of 228,632 adults in Wolverhampton’s city area.

Main Outcome Measures Hospital admissions and mortality.

Results 5558 patients admitted, 686 died (556 in hospital); 930 were COVID-19 admissions (CA),of which 270 were hospital COVID deaths, 47 non-COVID deaths, 36 deaths post-discharge; 4628 non-COVID-19 admissions (NCA), 239 in-hospital deaths (2 COVID), 94 deaths post-discharge. 223,074 adults not admitted, 407 died. Age, gender, multi-morbidity and Black ethnicity (OR 2.1 [95% CI 1.5-3.2] p<0.001, absolute excess risk of <1/1,000) were associated with COVID-19 admission and mortality. The South Asian cohort had lower CA and NCA, lower mortality (CA (0.5 [0.3-0.8], p<0.01), NCA (0.4 [0.3-0.6] p<0.001), community deaths (0.5 [0.3-0.7] p<0.001). Despite many common risk factors for CA and NCA, ethnic groups had different admission rates, and within-groups differing association of risk factors. Deprivation impacted only in White ethnicity, in the oldest age bracket and in a lesser (not most) deprived quintile.

Conclusions Wolverhampton’s results, reflecting high ethnic diversity and deprivation, are similar to other studies for Black ethnicity, age and comorbidity risk in COVID-19 but strikingly different in South Asians and for deprivation. Sequentially considering population and then hospital based NCA and CA outcomes, we present a complete single health-economy picture. Risk factors may differ within ethnic groups; our data may be more representative of communities with high BAME populations, highlighting the need for locally focussed public health strategies. We emphasise the need for a more comprehensible and nuanced conveyance of risk.

Strengths and limitations of this study

  • The rapidly developing COVID-19 pandemic has led to numerous studies (published, preprints and national public health reports) of its health impacts in relation to ethnicity, co-morbidities and other factors; few studies, however, have attempted to evaluate infection patient data in terms of morbidity and mortality in context of the feeder population and most are limited by incompleteness of data and inability to account for regional variations in factors such as ethnicity and deprivation

  • Our observational study used a high quality and complete dataset from the local population and the hospital serving it to examine the association of purported risk factors with severity and mortality and the results reveal the importance of evaluating such risks in the local, and not just national, population setting taking into account the local variations in patient backgrounds

  • We found an increased risk of COVID-19 mortality for Black ethnicity (OR 2.1) but a decreased risk (OR 0.5) for South Asians, compared with white ethnicity; Our analysis reveals that a nuanced approach to studying risk factors associated with COVID-19 severity and mortality is important – factoring in regional variation in ethnicity, deprivation etc. specifically linked to the source population

  • We suggest, based on our findings, that understandably rapid analysis and dissemination of studies of COVID-19 risk needs to be tempered by careful consideration of the real implications; we further urge caution in conveying risk messages to the wider community because of an ethical imperative to ensure such messages do not lead to unnecessary fear and deter individuals, particularly from specific ethnic backgrounds, from seeking needed medical assistance.

Introduction

In understanding the natural history of disease, fundamental to healthcare, the COVID-19 (hereafter referred to as “COVID”) pandemic highlights issues within data repositories. Constructing multiple source datasets has complexity in case definition, data acquisition, integration, quality, completeness, coding accuracy and the clinical meaning of analysis outcomes. 1-4 Emphasising this challenge, national UK data were initially collated via the Patient Notification System, requiring a positive swab test up until the 28th April 2020 but revised to include clinical definitions given an estimated false negative rate testing rate of up to 29%. 5-8 Well-established primary care databases, may have significant inaccuracy and do not include hospital secondary care information.9 A large UK primary care epidemiological study also used national COVID (SARS-CoV-2) positive swab cases for case definition.2 Conversely, secondary care case series and international registry studies for specific diseases are not linked to primary care datasets.10-14 Therefore important caveats exist in utilising and interpreting such data and drawing clinically important conclusions regarding the adverse associations of ethnicity with outcomes.2, 15

Our objective, therefore, was to establish a tightly governed comprehensive, multi-source, integrated, quality assured local structured clinical data set, used for the purposes of direct care, define cohorts at risk, to systematically improve clinical coding and mortality recording accuracy, and to enable an informed understanding of factors influencing hospital activity, including admissions. This approach should ultimately inform public health initiatives. We present a proof of principle study to evaluate the utility of this approach in relation to a single UK city wide health district, reporting our findings regarding population wide factors that may have an association with 2 key COVID outcomes, hospital admission and mortality, over the first 12 weeks of the pandemic in this City.

Methods

General Method

The time frame spanned 1/3/2020 to 24/05/2020.

Data were integrated into an SQL database from primary care, community and hospital clinical and pathology systems for all people resident in Wolverhampton or registered to Wolverhampton practices and those from immediately adjacent districts with emergency admission to New Cross Hospital (NXH). Only those alive at the start point were included and subsequently death and date of death were tracked. The final total population aged >18 was 228,632, of whom 1063 were resident but not Wolverhampton GP registered, 1521 who were registered but not City resident and 1026 neither resident nor registered from immediately surrounding areas with an emergency admission to NXH, such that 99.5% of the cohort were registered and/or resident constituting 88% of COVID admissions and 91% COVID deaths. The Index of Multiple Deprivation was allocated according to postcode. Unavailable smoking status (15%) was reallocated to “non-smoker”. Missing body mass index (22%) were replaced by the age-related (5-year band) mean value in the cohort. Ethnicity data from all sources were reviewed, only unambiguous data were accepted, and recoded into Caucasian (White), South-Asian, Black, Mixed Ethnicity Chinese with 7.5% remaining “Unknown”. Comorbidities were accrued and cross-checked from primary care and hospital coding to include: Asthma, COPD, Diabetes, Hypertension, Coronary Artery Disease, Stroke and Peripheral Arterial Disease, Chronic Heart Failure, Atrial Fibrillation, Chronic Kidney Disease, Cancer, Dementia, Depression, other Mental Health Disorders, Epilepsy, Learning Difficulties, Osteoarthritis, Rheumatoid arthritis as well as recorded nursing home residency and palliative care status. Non-elective admissions over the preceding 12 months were ascertained. During admission, the COVID clinical status was recorded by the Infection Diseases team or the clinical team in daily updates as “COVID definite”, “COVID probable” or “not COVID”. Formal endpoint coding was in duplicate with a rolling triangulation audit in place comparing the clinical diagnosis, the coded diagnosis and COVID pathology status for coding accuracy. Mortality and cause of death were certified in our Medical Examiner System and also continuously cross-checked against the coded status. COVID coding and death certification arbitration were supported by the accountable senior responsible consultant (AV). Further validation against the National Strategic Tracing Service captured deaths outside hospital.

Statistical Analysis

This was undertaken in SPSS v26. Factors analysis of all variables considered confounding effects and redundancy, yielding a 9 component rotated solution explaining 48% of the variance: deprivation and ethnicity were strongly co-associated in a single component whilst the two principal outcome measures of hospital admission and mortality were in another distinct component. We adopted a multinomial regression analysis approach. The analysis was undertaken sequentially to ensure an a priori justification for further analysis. Statistical tests are described in the text and their results considered significant at p<0.05.

Ethical Approval

This was not sought nor deemed necessary since this work represents a continuous quality improvement programme of the informatics component of service changes required between various local NHS organisations for integrated working stipulated during the COVID 19 emergency. Data governance was in line Trust policy and with the COVID emergency directive of NHS England.

Patient and Public Involvement

None (not applicable to this type of study)

Results

Hospital Admissions

The population characteristics are shown in Table 1, grouped according to admission status (No Admission, Non-COVID Admission and COVID Admission (NA, NCA, CA respectively) together with their mortality rates. Compared to NA, there was an increased association of all variables from NCA through to CA including age, the number of comorbidities, most individual comorbidities, the surrogate measures of dependency, and prior history of emergency admissions. Male gender, BMI, IMD and smoking status were significantly different. Ethnic minority groupings were significantly different between admission types with the South Asian population prevalence in CA being 46% of that in the comparator NA population whilst the Black population appeared to have a 56% excess. Table 2 gives further numerical detail.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1

The demographic, clinical features and mortality outcomes of a whole adult population (n= 228,632) categorised according to their hospital admission status during 12 weeks of the UK COVID-19 pandemic. Data are presented as the mean+-SD or as percentages. Between groups analysis is by ANOVA or by Chi square for scale or categorical variables respectively. Co-morbidities are listed in descending order of frequency.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2

COVID admission and death by ethnic category showing numbers, absolute rates per 1000 population, and the excess risk and unadjusted OR s (95% CI) vs the White group as comparator.

The 3 hospital admissions categories (NA, NCA, CA) were taken as the response variable and submitted to multinomial regression (Table 3). The complete model was highly significant (χ2=8,869.1, p<0.001). Male gender was more prevalent in CA. Age distribution (Figure 1a) differed significantly for CA and NCA versus NA, and the two admission groups differed significantly from each other, reflecting the higher mean age in CA. The pattern for deprivation (Figure 1b) showed the peak admission rates to be in the second least deprived quintile with the most deprived quintile not being significantly different from the least deprived quintile, whilst the 2 admission groups did not differ significantly from each other in this regard. There was a decreased relative risk for admission in either group with current or previous smoking. Both admission groupings had a significantly increased history of prior emergency admissions, established multi-morbidity, being nursing home resident or in a palliative phase of care with these latter two characteristics in significantly higher prevalence in CA compared to NCA. Both groups shared individual comorbidities in higher risk, but with some differential effect for diabetes, hypertension, atrial fibrillation and peripheral vascular disease which were increased in CA.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3

Multinomial regression for the association of factors with COVID or Non COVID related emergency hospital admissions (HA) compared to the reference category of those not admitted (n=223, 074). Data are the Odds Ratio (OR) with 95% confidence intervals. For age and IMD as categorical ordinal variables (data ranges shown), the comparators were the youngest and least deprived quintiles respectively. Comorbidities associations are listed in descending OR order for the CA group. The comparison of CA vs NCA was by binary logistic regression. Variables not listed (Table 1) were excluded stepwise as not significant.

Figure 1:
  • Download figure
  • Open in new tab
Figure 1: Age and deprivation in relation to hospital admission and in whole population

The association of age (a.) and deprivation (b.) with hospital admission type. Figure 1c. shows the inter-relationship of age, deprivation and ethnicity in the whole population (n=228,632) (Other / Unknown ethnic groups not shown).

The South Asian ethnic group was less likely to have a CA or NCA (60% and 50% crude percentage reduced risk respectively) compared to the White ethnic reference category whilst the Black ethnic group shared the significant propensity not to have an NCA but had a markedly increased relative risk (70%) for CA. Ethnicity related outcomes were examined specifically amongst those with COVID admission, by comparing those admitted to those not admitted within their ethnic category in separate binary regression analyses (all χ2 >252.4, p<0.001) (Table 4). Age, gender, preceding emergency admissions, palliative phase, comorbidity, and nursing home residence were significant associations in 2 or more of the ethnic groups. Of note, patterns of significantly associated individual comorbidities were different between the ethnic groups: Black - hypertension, atrial fibrillation and cardiac failure; South Asian - diabetes, peripheral vascular disease and atrial fibrillation; White - specific association with COPD, CKD, and RA. Deprivation had a significant impact only in the White group. The inter-relationship of age, deprivation with ethnicity and the impact of white ethnicity in the oldest quintile in lesser deprived categories can be seen in Figure 1c. In a simplified model of admission type and ethnicity (χ2=4542.9, p<0.001) with only age and deprivation entered categorically together with their interaction (χ2= 412.7, p<0.001), the ORs for CA compared to Whites were Black 2.08 (1.70 - 2.57) (p<0.001) and South Asian 0.56 (0.44 – 0.70) (p<0.001), with both groups still less likely to have NCA (p<0.001).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4

Outcomes by individual ethnic category for those specifically with COVID hospital admissions compared those not admitted within individual ethnic grouping as examined in binary regression analysis. Values are the Odds Ratio with 95%CI.

Absolute risk of COVID Admission within Ethnic groups

The absolute risk from COVID hospital admission was 4.8 / 1000 population and Table 2 shows this broken down by ethnic grouping giving numbers, percentages, absolute risk and excess risk with unadjusted ORs compared to the White group, with the South Asian group showing a lower and the Black group a higher absolute risk as reflected in the unadjusted ORs.

Mortality outcomes

COVID and non-COVID hospital death and death in the community (CHD, NCHD, DIC) were analysed in stepwise backwards multinomial regression (χ2=5,548.3, p<0.001) (Table 5). Male gender was significantly positively associated with mortality in all 3 categories. Increasing age was a significant factor, but there was no significant difference in age quintile distribution (χ2=12.168, p= 0.144, ns) with 89%, 84% and 86% in the oldest quintile in the CHD, NCHD and DIC groups respectively. For deprivation, for CHD and NCHD the pattern mirrored that of hospital admission with significantly increased mortality rates in the lesser deprived quintiles but not in the highest quintile whereas in DIC, a significant effect showing an increased mortality rate was only seen in the most deprived quintile. All categories shared a propensity for greater prior emergency admissions, multi morbidity and being in a palliative phase of care whilst being nursing home residency was associated with death in the community rather than hospital death. Individual morbidities varied in their associations, noting that diabetes and chronic kidney disease were in increased association with mortality only in the CHD group. The Black ethnic minority had significantly higher, and the South Asian significantly lower COVID hospital mortality rate, proportionately mirroring admission rates. Directly comparing CHD to NCHD confirmed a significantly increased association with Black ethnicity (OR 4.6 (2 - 10.2), p<0.003), diabetes (OR 1.5 (1 - 2.3), p<0.005) and chronic kidney disease (OR 1.6 (1.1 - 2.3), p<0.004) and an even greater negative association with current of previous smoking (OR 0.1 (0 - 0.3), p<0.002).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 5

Multinomial regression of mortality outcomes over the 12 weeks period for those that died (n= 1093) either in the community (n= 537) or Non COVID (n = 284) and COVID related (n= 272) hospital deaths (HD) (See Table 1) compared to those who were alive (n = 227, 539). Results are the Odds ratio with 95% confidence intervals. For age and IMD categories the comparators were the youngest and least deprived quintile respectively. Variables not listed from Table 1 were excluded stepwise (backwards) as not significant.

Absolute risk of COVID Death by Ethnic group

Specifically for COVID death, Table 2 shows numbers, percentages, absolute risk and excess risk with unadjusted ORs for the ethnic minorities compared to the White group and Figure 2a shows the distribution of mortality outcome by ethnic category (χ2 = 126.1, p<0.001). The absolute risk of COVID death was 1.32, 0.73 and 2.2 per 1000 population in the White, South Asian and Black ethnic groups and the excess risk was -0.61 (negative) and 0.85 deaths per 1000 population in South Asians and Blacks versus Whites respectively. Compared to the White population, the unadjusted OR (95% CI) for COVID death for the Black and Asian groups was 1.6 (1.2 – 2.3) and 0.5 (0.4 – 0.8) respectively (both p<0.01). The ethnic groups differed significantly in age (White 50±20, South Asian 45±16, Black 45±17 years, F=1868.9, P<0.001) and age was the dominant factor associated with hospital admission and death (Tables 1, 3, 4, 5). To avoid any potential misrepresentation of mortality outcomes by statistical age adjustment, the absolute effects were considered for the oldest quintile only where 84% of all COVID deaths occurred, in which case the ORs were Black 3.9 (2.7 – 5.6) (p<0.001) and South Asian 0.9 (0.6 – 1.4) (p=0.72, ns) (Figure 2b).

Figure 2:
  • Download figure
  • Open in new tab
Figure 2: Mortality by ethnicity

Crude mortality by ethnic grouping as percentages (a. χ2 = 184·4, p<0·001), within the oldest quintile (b. χ2=92·2, p<0·001) or restricted to those with a COVID admission excluding those with a non-COVID death (c. χ2=5.92, p=0.115, ns), (Other / Unknown ethnic categories are not shown but were included in the analysis).

COVID Hospital admission and COVID mortality

By introducing hospital admission status, the COVID mortality ORs were Black 1.3 (0.9 – 2.0) (p=0.206, ns) and South Asian 1.5 (0.9 – 2.3) (p=0.098, ns) were similar, indicating similar in hospital mortality in contrast to the whole population effect. To negate this potential effect of prior propensity for acquisition of serious COVID infection, and focusing on the Black and South Asian minorities compared to the White majority, a narrower assessment of those who were admitted with COVID and had a COVID death was made. Amongst 930 COVID admissions, excluding those with a COVID admission but with non-COVID death (n = 83 (9%), COVID death occurred 270 (32%) (White 189, South Asian 32, Black 38, Other 11). The ORs for the association of ethnicity with COVID mortality were Black 1.2 (0.7 – 1.8) (p=0.423, ns) and South Asian 1.6 (1.0 – 2.5) (p= 0.075, ns) (χ2= 5.92, p= 0.115, ns) (Figure 2c). Utilising the full model with all independent variables, including age, which remained significantly different between ethnic groups (F= 13.23, p<0.001), then the significantly associated variables were age, gender, smoking status, body mass index, palliative phase of life, multi-morbidity and the individual comorbidities of cardiac failure, chronic kidney disease and peripheral vascular disease but not ethnic grouping or deprivation score (Table 6). Finally, Table 2 shows the absolute risks of COVID death in COVID hospital admission and unadjusted ORs which are consistent with the findings of the modelled data.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 6.

Multinomial regression amongst those with a COVID admission restricted to the White, Black and South Asian ethnic groups (n=797) comparing to those with COVID death (n= 259) to those who were alive at 12 weeks. Results are the Odds Ratio with 95% confidence intervals. Variables not listed from Table 1 were excluded stepwise (backwards) as not significant.

Discussion

Principal findings

Over and above known general associations with hospital admission and mortality, our study suggest a complex association of deprivation and points to heterogeneity of the impact of ethnicity, both of which may vary by locality. We highlight the need for local health economies to have robust, accurate and integrated clinical data in order to assess and inform local decisions making and, in particular, at a time of heightened anxiety, we raises a concern about the conveyance of risk to local communities. The crucial differences in relationship to other studies are as follows:

General Associations

Uncontroversially, factors associated with non-COVID or COVID hospital admission and death included age, gender, prior emergency admissions, and palliative phase of life, nursing home residence and multi-morbidity with specific comorbidities associated with COVID admission or death and with ethnic status. Any association of smoking with better COVID outcomes, observed in other studies, 2,17 may be refuted when taken in the context of this being common to non-COVID admissions and death during this period.

COVID vs Non COVID Admissions

The significant differences were age, gender and degree of comorbidity complexity (palliative care, nursing home) but as it is likely that patterns of emergency admissions differed at this time, comparisons of COVID to non-COVID hospital admission may have little relevance to COVID outcomes, noteworthy for studies that have reported on COVID hospital admission alone.12,13,18

Deprivation

For hospital non-COVID and COVID admission and death, the pattern was for excess in lesser deprived quintiles in the White ethnic population but not within ethnic minority groups where deprivation was not a significant factor. This contrasts with other studies: 2, 5 in some deprivation was not a significantly associated factor in fully adjusted models,19 whilst other UK studies, 18 and most overseas studies, have not considered this.12, 13 Following the H1N1 pandemic influenza of 2009, many studies indicated effects of deprivation including a rural urban divide impact,20 as is seen in this pandemic.21 Our findings within a health economy with significant deprivation call for the need to explore this association within larger studies specifically within urban areas.

Ethnicity

We note that a recent meta-analysis shows heterogeneity in the association of ethnicity to COVID mortality;22 in a large population study reporting adverse odds ratios for all ethnic groups, their crude unadjusted data showed significantly increased risk in the Black (χ2 = 17.464, p<0.001) but not in the South Asian group (χ2 =3.238, p=0.072),2 as shown in another population level study;21 in the largest reported hospital admission series both ethnic groups had significantly lower unadjusted mortality rates,15 whilst in their modelled data no effect was seen amongst Blacks; from New York there was no adverse ethnicity signal,12,13 and early reported adverse ethnicity outcomes in the 2009 UK flu pandemic,23 did not stand subsequent review.24 We find our Black population had significantly higher and the South Asian lower crude and adjusted COVID admission rates compared to Whites, also observing that both ethnic subgroups had lower non-COVID hospital admissions, further contextualising the strong effect in the Black cohort. In both groups, their crude and adjusted patterns of COVID mortality mirrored that of COVID hospital admission but from the numerical base of COVID admission, there was no significant difference between the Black and South Asian compared to the White groups, highlighting pitfalls of examining effects in isolation. Our data in the Black population is broadly in keeping with some studies showing excess COVID hospitalisation and mortality but the South Asian group’s lower absolute and adjusted rate of admission and death from COVID 19 are strikingly different. Given the variation in findings to date, we do not consider this an “unexpected finding”, and hypothesise that many local population factors are at play including population density, family size, housing, duration of immigration, country of birth (including UK born) and occupation and the precise ethnic group within the ‘South Asian’ population may well be of importance. A recent updated analysis by the UK Office for National Statistics has emphasised that “ethnic differences in mortality involving COVID-19 are most strongly associated with demographic and socio-economic factors, such as place of residence and occupational exposures, and cannot be explained by pre-existing health conditions” which conclusion is consistent with our locally-dictated findings.25 Otherwise within BAME groups we find specific individual comorbidities vary in their association with COVID risks: in South Asians these are diabetes, peripheral vascular disease and atrial fibrillation; in the Black population hypertension, atrial fibrillation and cardiac failure; in white ethnicity most co-morbidities but in particular COPD, chronic kidney disease and rheumatoid arthritis.

The conveyance of risk

Public health messages are vital to convey but population adjusted risk rates may confuse, adversely impacting behaviors such that, it is feared, hospital admission patterns may change unfavourably. Absolute, absolute excess, relative, unadjusted and adjusted risk is complex to communicate even for healthcare professionals making them susceptible to reasoning errors and misinterpretation of probabilities 26 and individuals, with erstwhile health risk, should know about the magnitude of risk in a way that can be conceptualised.27,28 For our Black population, the fully-modelled OR for COVID mortality was 2.1, the absolute risk 2.2 / 1000 people or an excess risk of 0.9/1000. A Black person in Wolverhampton ought to be informed that “twice as likely to die of COVID” compared to the White community can also mean “a 1 in 1000 excess risk”.

Strengths and Weaknesses

Combining Wolverhampton’s health data evaluated our local population’s heterogeneous demographic and its associations with community or hospital non-COVID and COVID hospital admission and mortality, uniquely approaching these outcomes simultaneously. This local nuance complements larger studies, informing appraisal of risk from an urban, and multi-ethnic and deprived setting, highlighting concerns of extrapolation from larger datasets to UK localities. An example of a particular strength of the data quality was the cross check ascertainment of COVID admission, without sole reliance on COVID testing, permitting specific categorisation of deaths (COVID, non-COVID and post discharge) rather than less accurately into global mortality.

Limitations of the study: This is a twelve-week evaluation spanning the pandemic’s upsurge and peak; the population and event number were comparatively small; cause of death in the community was unknown and it is likely that people died away from the hospital undiagnosed with COVID 19 ; some data were missing but this was mitigated; whilst being aligned to the population at 99.5% concordance, hospital data were not totally drawn from the City population, which varied by GP registration, residency, or admission from immediately surrounding areas and a small proportion of admissions were non-resident or non-registered, so this is not strictly an epidemiological study but an observational study comparing defined cohorts in tiers of analysis (e.g. COVID death amongst COVID admissions) where this caveat does not apply.16

Implications for clinicians and policy makers

We show that a variety of recognised factors were associated with COVID death, as with non-COVID death. At our local level, COVID admission and death were not strongly associated with worsening deprivation, with a novel potential different relationship in the White population.

Higher absolute and adjusted COVID admission and mortality occurred in the Black population whilst they were reduced in Wolverhampton’s South Asian community. We point out the non-significant association between in-hospital COVID-19 case fatality and ethnicity, raising the probability that COVID-19 mortality relates to differential risks of exposure, susceptibility and disease contraction before hospital admission, let alone the possible avoidance of hospital admission. Two important considerations are the potential excessive use of multiple factors and the disruption of the perspective from a population’s base through hospital admissions to COVID specific admission, leading to widely varying conclusions, highlighting the difficulties of using observational data and the potential for Collider bias.29 We support the case for more localised population-based studies of both hospital admission and subsequent death, such as ours, in which the denominator and numerator populations can be clearly linked and are fully and transparently ascertained and characterised. To avoid associations in the data being due to the way in which data are sampled, local health economies should be mandated to link hospital and primary care data across their population level down to the un-anonymised individual level; they should, in preparation for future epidemics, have data quality mechanisms in place to ensure accuracy in their demographics, the accrual of important missing data and the triangulation of key outcomes to minimise false positive and negative results. This includes the need to have a robust, systematic, accurate and timely approach to the recording of death whether in the community or hospital setting. A defined data set and its capture in routine clinical systems seems apposite.30 Accepting that variation in findings in different population subsets is both inevitable and valid, we would suggest the need for the public health and research community to accommodate uncertainty in emergent evidence, learning from the experience of previous viral pandemics. This includes the need to have a robust, systematic, accurate and timely approach to the recording of death whether in the community or hospital setting.31

Future research

Perhaps most crucially we argue that, in reporting future research of this kind during the current pandemic and beyond, there is an ethical obligation for the standardisation of the conveyance of risk in a manner that spans the absolute to the relative so that is easily comprehensible to the individuals and populations at risk and others, including health professionals, politicians and the media, all matters in which the editorial and peer review mechanism of our medical journals have a vital role.

Data Availability

Anonymised data may be obtained on reasonable request from the corresponding author

Author contributions

Accountable senior author BMS; Data analysis, manuscript writing: BMS, JB, SJD, AV; Preparation for submission: SJD, BMS, JB; Database quality, data integration and data quality and integration: AV, BMS, VK; Reading drafts as lay expert: SM; Statistical advice: AN; All authors contributed intellectual content during the drafting and revision of the work and approved the final version.

Transparency declaration

BMS affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained

Funding

None

Competing interest statement

All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

Data Sharing

Anonymised data will be shared on reasonable request to the corresponding author

Footnotes

  • Copyright: The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ editions and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence

References

  1. 1.↵
    Xu B, Kraemer MUG; Open COVID-19 Data Curation Group. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis. 2020 May;20(5):534. doi: 10.1016/S1473-3099(20)30119-5
    OpenUrlCrossRefPubMed
  2. 2.↵
    Williamson EJ, Walker AJ, Bhaskaran K, et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients [published online ahead of print, 2020 Jul 8]. Nature. 2020;10.1038/s41586-020-2521-4. doi:10.1038/s41586-020-2521-4
    OpenUrlCrossRefPubMed
  3. 3.
    Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [retraction of: Lancet. 2020 May 22;:]. Lancet. 2020;395(10240):1820. doi:10.1016/S0140-6736(20)31324-6
    OpenUrlCrossRef
  4. 4.↵
    Rubin EJ, Baden LR, Morrissey S, Campion EW. Medical Journals and the 2019-nCoV Outbreak. N Engl J Med. 2020;382(9):866. doi:10.1056/NEJMe2001329
    OpenUrlCrossRef
  5. 5.↵
    Public Health England. Disparities in the risk and outcomes of COVID- 19.https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892085/disparities_review.pdf (Accessed 20-07-20)
  6. 6.
    Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths (accessed 20-07-20)
  7. 7.
    Willett K on behalf of NHS England and NHS Improvement. COVID–19 Patient Notification System (CPNS) https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/C0389-update-to-cpns-reporting-letter-27-april-2020.pdf (accessed 20-07-20)
  8. 8.↵
    Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications [published online ahead of print, 2020 Jun 5]. N Engl J Med. 2020;10.1056/NEJMp2015897. doi:10.1056/NEJMp2015897
    OpenUrlCrossRefPubMed
  9. 9.↵
    Bradley SH, Lawrence NR, Carder P. Using primary care data for health research in England - an overview. Future Healthc J. 2018;5(3):207–212. doi:10.7861/futurehosp.5-3-207
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3
    OpenUrlCrossRefPubMed
  11. 11.
    Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc2010419
    OpenUrlCrossRefPubMed
  12. 12.↵
    Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. Published 2020 May 29. doi:10.1136/bmj.m1996
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.BMJ. 2020;369:m1966. Published 2020 May 22. doi:10.1136/bmj.m1966
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859–866. doi:10.1136/annrheumdis-2020-217871
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Harrison, EM, Docherty AB, Barr B, et al. Ethnicity and Outcomes from COVID-19: The ISARIC CCP-UK Prospective Observational Cohort Study of Hospitalised Patients (5/31/2020). Available at SSRN: https://ssrn.com/abstract=3618215 or http://dx.doi.org/10.2139/ssrn.3618215
  16. 16.↵
    Pearce N. Classification of epidemiological study designs. Int J Epidemiol. 2012;41(2):393–397. doi:10.1093/ije/dys049
    OpenUrlCrossRefPubMed
  17. 17.↵
    Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? [published online ahead of print, 2020 May 9]. Intern Emerg Med. 2020;1–8. doi:10.1007/s11739-020-02355-7
    OpenUrlCrossRef
  18. 18.↵
    Docherty AB, Harrison EM, Green CA, et al. Features of 201133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. Published 2020 May 22. doi:10.1136/bmj.m1985
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Niedzwiedz CL, O’Donnell CA, Jani BD, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160. Published 2020 May 29. doi:10.1186/s12916-020-01640-8
    OpenUrlCrossRef
  20. 20.↵
    Rutter PD, Mytton OT, Mak M, Donaldson LJ. Socio-economic disparities in mortality due to pandemic influenza in England. Int J Public Health. 2012;57(4):745–750. doi:10.1007/s00038-012-0337-1
    OpenUrlCrossRefPubMed
  21. 21.↵
    de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study [published online ahead of print, 2020 May 15]. Lancet Infect Dis. 2020;S1473-3099(20)30371-6. doi:10.1016/S1473-3099(20)30371-6
    OpenUrlCrossRefPubMed
  22. 22.↵
    Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. 2020;23:100404. Published 2020 Jun 3. doi:10.1016/j.eclinm.2020.100404
    OpenUrlCrossRefPubMed
  23. 23.↵
    Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax. 2010;65(7):645– 651. doi:10.1136/thx.2010.135210
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Nyland GA, McKenzie BC, Myles PR, et al. Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK. Epidemiol Infect. 2015;143(6):1129–1138. doi:10.1017/S0950268814001873
    OpenUrlCrossRef
  25. 25.↵
    Office for National Statistics https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/updatingethniccontrastsindeathsinvolvingthecoronaviruscovid19englandandwales/deathsoccurring2marchto28july2020#main-points (accessed 22/10/20)
  26. 26.↵
    Grant RL. Converting an odds ratio to a range of plausible relative risks for better communication of research findings [published correction appears in BMJ. 2014;348:g2124]. BMJ. 2014;348:f7450. Published 2014 Jan 24. doi:10.1136/bmj.f7450
    OpenUrlFREE Full Text
  27. 27.↵
    Paling J. Strategies to help patients understand risks. BMJ. 2003;327(7417):745–748. doi:10.1136/bmj.327.7417.745
    OpenUrlFREE Full Text
  28. 28.↵
    Ahmed H, Naik G, Willoughby H, Edwards AG. Communicating risk. BMJ. 2012;344:e3996. Published 2012 Jun 18. doi:10.1136/bmj.e3996
    OpenUrlFREE Full Text
  29. 29.↵
    Griffith GJ,Morris TT,Tudball M, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Medrxiv preprint doi.org/10.1101/2020.05.04.20090506
  30. 30.↵
    Cross M. Show us the data: why clinical outcomes matter. BMJ. 2012;344:e66. Published 2012 Jan 10. doi:10.1136/bmj.e66
    OpenUrlFREE Full Text
  31. 31.↵
    Luce T. COVID 19: death certification in England and Wales. BMJ. 2020;369:m1571. Published 2020 Apr 21. doi:10.1136/bmj.m1571
    OpenUrlFREE Full Text
Back to top
PreviousNext
Posted November 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The risk of COVID hospital admission and COVID mortality during the first COVID 19 wave with a special emphasis on Ethnic Minorities: an observational study of a single, deprived, multi ethnic UK health economy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The risk of COVID hospital admission and COVID mortality during the first COVID 19 wave with a special emphasis on Ethnic Minorities: an observational study of a single, deprived, multi ethnic UK health economy
Baldev M Singh, James Bateman, Ananth Viswanath, Vijay Klaire, Sultan Mahmud, Alan M Nevill, Simon J Dunmore
medRxiv 2020.11.20.20224691; doi: https://doi.org/10.1101/2020.11.20.20224691
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The risk of COVID hospital admission and COVID mortality during the first COVID 19 wave with a special emphasis on Ethnic Minorities: an observational study of a single, deprived, multi ethnic UK health economy
Baldev M Singh, James Bateman, Ananth Viswanath, Vijay Klaire, Sultan Mahmud, Alan M Nevill, Simon J Dunmore
medRxiv 2020.11.20.20224691; doi: https://doi.org/10.1101/2020.11.20.20224691

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3826)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)